Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Even as Climate Change Takes Center Stage, FuelCell Energy Doubts Remain

By Josh Enomoto, InvestorPlace Contributor

Given the political climate that now strongly favors green energy, FCEL stock should be moving higher. That it isn’t is a clear warning that investors must tread carefully with FuelCell Energy.

Take a Hint from Gold Prices and Run from Wells Fargo Stock

By Josh Enomoto, InvestorPlace Contributor

What many investors need to realize before gambling on Wells Fargo stock is that gold prices are rising. Given that gold is just a commodity, this should clue you in regarding the viability of WFC.

With Its Vaccine Trail, Moderna Addresses Racial Disparity Head On

By Josh Enomoto, InvestorPlace Contributor

With the race to find an effective vaccine tightening, MRNA stock just might have the inside lane due to lingering question marks about competing vaccine types. If so, Moderna can also do much good in addressing racial conflict in America.

Here’s Why You Should Consider an Exit Plan from Marathon Oil Stock

By Josh Enomoto, InvestorPlace Contributor

Think oil's coming back? A gamble on MRO stock makes sense. But fundamentals are getting uglier by the day, Marathon is unpalatable to all but the most extreme speculators.

If Load Factors Matter, JetBlue Airways Is in Trouble

By Josh Enomoto, InvestorPlace Contributor

With coronavirus cases declining and JetBlue adding more flights, the bullish narrative for JBLU stock appears enticing. However, the underlying company has not performed well relative to its competitors.

Load More